Yes
100%
No
0%
Voting closed
Voting is closed.
Votes only — no stakes, just conviction.
✨ AI says 48% Yes
Immunotherapy is a perennial favorite with three Nobel wins since 2015, but the Nobel Committee often recognizes diverse fields; competition from aging/longevity, CRISPR variants, and other breakthroughs is intense.
Rules
Resolves YES if the Nobel Assembly's official announcement at nobelprize.org cites immunotherapy (CAR-T, checkpoint inhibitors, or related cancer/disease immunology advances) as the primary rationale for the 2026 prize.
Share this with an ambitious friend